Select Language:
For many years, researchers believed that metformin, one of the most commonly prescribed medications for Type 2 Diabetes, primarily worked by targeting the liver to decrease sugar production. However, a recent study from Northwestern University suggests that the drug’s main effect might actually stem from its interaction with the gut.
The study, published in *Nature Metabolism*, reveals that metformin reduces blood sugar levels by altering how intestinal cells utilize energy. Instead of mainly acting on the liver, the medication appears to encourage gut cells to absorb and burn more glucose, thereby aiding in the removal of excess sugar from the bloodstream.
This discovery could significantly shift scientific understanding of how one of the world’s most prescribed diabetes drugs works. Glucose serves as the body’s primary quick energy source, but having too much in the blood can lead to insulin resistance and long-term damage to blood vessels and organs. The researchers found that metformin disrupts energy production within mitochondria—tiny structures inside gut cells often called the cell’s power plants, because they produce the energy needed for proper function.
By slowing down this mitochondrial energy process, metformin causes intestinal cells to consume more glucose directly. Navdeep Chandel, a study author, explains that the intestine effectively acts like a sponge, soaking up extra sugar from the blood.
The research builds on earlier findings from Chandel’s lab, which indicated that metformin inhibits a crucial mitochondrial component known as complex I. This new study highlights the gut as the primary site where this mechanism influences blood sugar regulation.
To test this, scientists used specially engineered mice with intestinal cells resistant to metformin’s effects. In these mice, the drug was much less effective at lowering blood sugar levels, strongly suggesting that the gut plays a key role in how metformin works.
The findings may also shed light on some of the unusual effects observed in people taking metformin, such as lower post-meal blood sugar, decreased appetite, and mild weight loss. These effects might occur because stressed gut cells release signals that influence metabolism and hunger cues.
One of these signals is a hormone called GDF15, which can signal the brain to reduce food intake. The study also found changes in citrulline, a compound produced in the small intestine’s mitochondria, reinforcing the idea that metformin has a significant impact on energy production within gut cells.
Additionally, the study identified similarities between metformin and berberine, a plant-based supplement sometimes promoted online as “nature’s Ozempic.” Researchers observed that berberine appears to influence the same pathway in the gut as metformin does.
However, Chandel emphasized that metformin has decades of rigorous scientific evidence backing its safety and effectiveness, while supplements like berberine haven’t undergone the same level of testing.
These insights could lead to the development of new diabetes treatments that specifically target the gut. Instead of focusing mainly on the liver, future therapies might aim to enhance the intestine’s ability to clear excess sugar from the blood more efficiently.
If you’re interested in reducing diabetes complications, consider exploring studies on five vitamins that may help prevent issues, as well as strategies for managing high blood pressure and diabetes with healthy foods. For more health updates, check out recent research on vitamin D and Type 2 Diabetes, and learn which fruits are better suited for people with diabetes.
ChatGPT
Perplexity
Gemini AI
Grok AI
